Massive Blood Transfusion in Patients with Ruptured Abdominal Aortic Aneurysm.
Eur J Vasc Endovasc Surg. 2016 Nov; 52(5):597-603.EJ

Abstract

OBJECTIVES

The aim was to study blood transfusions and blood product ratios in massively transfused patients treated for ruptured abdominal aortic aneurysms (rAAAs).

METHODS

This was a registry based cohort study of rAAA patients repaired at three major vascular centres between 2008 and 2013. Data were collected from the Swedish Vascular Registry, hospitals medical records, and local transfusion registries. The transfusion data were analysed for the first 24 h of treatment. Massive transfusion (MT) was defined as 4 or more units of red blood cell (RBC) transfused within 1 h, or 10 or more RBC units within 24 h. Logistic regression was used to calculate the odds ratio of 30 day mortality associated with the ratios of blood products and timing of first units of platelets (PLTs) and fresh frozen plasma (FFP) transfused.

RESULTS

Three hundred sixty nine rAAA patients were included: 80% men; 173 endovascular aneurysm repairs (EVARs) and 196 open repairs (ORs) with median RBC transfusion 8 units (Q1-Q3, 4-14) and 14 units (Q1-Q3, 8-28), respectively. A total of 261 (71%) patients required MT. EVAR patients with MT (n = 96) required less transfusion than OR patients (n = 165): median RBC 10 units (Q1-Q3, 6-16.5) vs. 15 units (Q1-Q3, 9-26) (p = .002), FFP 6 units (Q1-Q3, 2-14.5) vs. 13 units (Q1-Q3, 7-24) (p < .001), and PLT 0 units (Q1-Q3, 0-2) vs. 2 units (Q1-Q3, 0-4) (p = .01). Median blood product ratios in MT patients were FFP/RBC (EVAR group 0.59 [0.33-0.86], OR group 0.84 [0.67-1.2]; p < .001], and PLT/RBC (EVAR 0 [0-0.17], OR 0.12 (0-0.18); p < .001]. In patients repaired by OR a FFP/RBC ratio close to 1 was associated with reduced 30 day mortality (p = .003). The median PLT/RBC ratio was higher during the later part of the study period (p < .001, median test), whereas there was no significant difference in median FFP/RBC ratio (p = .101, median test).

CONCLUSION

The majority of rAAA patients undergoing EVAR required MT. EVAR patients treated with MT had lower FFP/RBC and PLT/RBC ratios than OR patients with MT. The mortality risk was lower with FFP/RBC ratio close to 1:1 in open repaired patients requiring MT. The 24 h PLT/RBC ratio increased over the study period.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Montan C
Department of Vascular Surgery, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: carl.montan@karolinska.se.
Hammar U
Department of Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Wikman A
Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
Berlin E
Department of Transfusions Medicine and Immunology, Skåne University Hospital, Lund University, Sweden.
Malmstedt J
Department of Vascular Surgery, Södersjukhuset, Stockholm, Sweden; Department of Vascular Surgery, Karolinska Institutet, Stockholm, Sweden.
Holst J
Department of Vascular Surgery, Skåne University Hospital, Lund University, Lund, Sweden.
Wahlgren CM
Department of Vascular Surgery, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.

MeSH

AgedAged, 80 and overAortic Aneurysm, AbdominalAortic RuptureBlood Vessel Prosthesis ImplantationEndovascular ProceduresErythrocyte CountErythrocyte TransfusionFemaleHemodynamicsHemorrhageHumansLogistic ModelsMaleOdds RatioPlatelet CountPlatelet TransfusionRegistriesRetrospective StudiesRisk AssessmentRisk FactorsSwedenTime FactorsTreatment Outcome

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

27605360